Coronary effects of neuropeptides in dogs: role of cyclooxygenase products as mediators.
Ertl
G
G
Medizinische Klinik, Universität Würzburg, West Germany.
Bauer
B
B
Gaudron
P
P
Kochsiek
K
K
D000818:Animals; D003326:Coronary Circulation / Q000187:drug effects*; D003327:Coronary Disease / Q000503:physiopathology; D004285:Dogs; D007213:Indomethacin / Q000494:pharmacology; D009478:Neuropeptide Y / Q000494:pharmacology; D009479:Neuropeptides / Q000494:pharmacology*; D009496:Neurotensin / Q000494:pharmacology; D010643:Phenoxybenzamine / Q000494:pharmacology; D011433:Propranolol / Q000494:pharmacology; D011451:Prostaglandin-Endoperoxide Synthases / Q000502:physiology*
D009478:Neuropeptide Y; D009479:Neuropeptides; D010643:Phenoxybenzamine; D009496:Neurotensin; D011433:Propranolol; D011451:Prostaglandin-Endoperoxide Synthases; D007213:Indomethacin